{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T20:16:59Z","timestamp":1775506619104,"version":"3.50.1"},"reference-count":87,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.cld.2024.03.008","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T12:15:56Z","timestamp":1714220156000},"page":"541-554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cerebral Aspects of Portal Hypertension"],"prefix":"10.1016","volume":"28","author":[{"given":"Karen Louise","family":"Thomsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristoffer","family":"Kj\u00e6rgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Lykke","family":"Eriksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette Munk","family":"Lauridsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik","family":"Vilstrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cld.2024.03.008_bib1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the study of liver diseases and the European Association for the study of the liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2024.03.008_bib2","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.23500","article-title":"Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study","volume":"51","author":"Jepsen","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2024.03.008_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-022-00366-6","article-title":"Hepatic encephalopathy","volume":"8","author":"Haussinger","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.cld.2024.03.008_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11011-008-9112-7","article-title":"Identifying the direct effects of ammonia on the brain","volume":"24","author":"Bosoi","year":"2009","journal-title":"Metab Brain Dis"},{"issue":"1","key":"10.1016\/j.cld.2024.03.008_bib5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hep.25995","article-title":"Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptake","volume":"57","author":"Dam","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2024.03.008_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hep.21001","article-title":"Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography","volume":"43","author":"Keiding","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2024.03.008_bib7","doi-asserted-by":"crossref","first-page":"114766","DOI":"10.1016\/j.ab.2022.114766","article-title":"Low cerebral energy metabolism in hepatic encephalopathy reflects low neuronal energy demand. Role of ammonia-induced increased GABAergic tone","volume":"654","author":"Sorensen","year":"2022","journal-title":"Anal Biochem"},{"issue":"2\u20133","key":"10.1016\/j.cld.2024.03.008_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0197-0186(02)00040-2","article-title":"Interorgan ammonia metabolism in liver failure","volume":"41","author":"Olde Damink","year":"2002","journal-title":"Neurochem Int"},{"issue":"15","key":"10.1016\/j.cld.2024.03.008_bib9","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3748\/wjg.v26.i15.1726","article-title":"Spontaneous porto-systemic shunts in liver cirrhosis: clinical and therapeutical aspects","volume":"26","author":"Nardelli","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.cld.2024.03.008_bib10","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/apt.16825","article-title":"Review article: post-TIPSS hepatic encephalopathy-current knowledge and future perspectives","volume":"55","author":"Gairing","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.cld.2024.03.008_bib11","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jhep.2020.10.004","article-title":"Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality","volume":"74","author":"Costa","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2024.03.008_bib12","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2024.03.008_bib13","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.jceh.2022.07.110","article-title":"Study of common precipitating factors and clinical outcome of hepatic encephalopathy in known case of cirrhosis of liver","volume":"12","author":"Modhavadiya","year":"2022","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2024.03.008_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101801","article-title":"A\u00a0systemic mechanism of increased transendothelial migration of leukocytes through the blood-brain barrier in hepatic encephalopathy","volume":"46","author":"Schaefer","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.cld.2024.03.008_bib15","doi-asserted-by":"crossref","first-page":"e13270","DOI":"10.1111\/apha.13270","article-title":"Peripheral inflammation induces neuroinflammation that alters neurotransmission and cognitive and motor function in hepatic encephalopathy: underlying mechanisms and therapeutic implications","volume":"226","author":"Cabrera-Pastor","year":"2019","journal-title":"Acta Physiol"},{"issue":"6","key":"10.1016\/j.cld.2024.03.008_bib16","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.jhep.2020.07.013","article-title":"Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy","volume":"73","author":"Rose","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.03.008_bib17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/hep.23656","article-title":"Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy","volume":"52","author":"G\u00f6rg","year":"2010","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2024.03.008_bib18","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.freeradbiomed.2012.01.006","article-title":"Systemic oxidative stress is implicated in the pathogenesis of brain edema in rats with chronic liver failure","volume":"52","author":"Bosoi","year":"2012","journal-title":"Free Radic Biol Med"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2024.03.008_bib19","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jhep.2020.11.013","article-title":"The microbiota in cirrhosis and its role in hepatic decompensation","volume":"75","author":"Trebicka","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2024.03.008_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4161\/gmic.28684","article-title":"The role of microbiota in hepatic encephalopathy","volume":"5","author":"Bajaj","year":"2014","journal-title":"Gut Microb"},{"issue":"2","key":"10.1016\/j.cld.2024.03.008_bib21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1872-034X.2012.01054.x","article-title":"Intestinal permeability and complications in liver cirrhosis: a prospective cohort study","volume":"43","author":"Benjamin","year":"2013","journal-title":"Hepatol Res"},{"issue":"5","key":"10.1016\/j.cld.2024.03.008_bib22","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"7516","key":"10.1016\/j.cld.2024.03.008_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cld.2024.03.008_bib24","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jhep.2021.09.010","article-title":"Rifaximin-alpha reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial","volume":"76","author":"Patel","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2024.03.008_bib25","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1365-2958.1993.tb01220.x","article-title":"Bacterial ureases: structure, regulation of expression and role in pathogenesis","volume":"9","author":"Collins","year":"1993","journal-title":"Mol Microbiol"},{"issue":"4 Pt 1","key":"10.1016\/j.cld.2024.03.008_bib26","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0016-5085(77)80135-2","article-title":"Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial","volume":"72","author":"Conn","year":"1977","journal-title":"Gastroenterology"},{"issue":"23","key":"10.1016\/j.cld.2024.03.008_bib27","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.3748\/wjg.14.3609","article-title":"Minimal hepatic encephalopathy matters in daily life","volume":"14","author":"Bajaj","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2024.03.008_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/hep.510280108","article-title":"Subclinical hepatic encephalopathy impairs daily functioning","volume":"28","author":"Groeneweg","year":"1998","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2024.03.008_bib29","doi-asserted-by":"crossref","first-page":"E92","DOI":"10.1111\/hepr.12227","article-title":"Prevalence of minimal hepatic encephalopathy and quality of life in patients with decompensated cirrhosis","volume":"44","author":"Mina","year":"2014","journal-title":"Hepatol Res"},{"issue":"11","key":"10.1016\/j.cld.2024.03.008_bib30","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1111\/imj.16053","article-title":"Serum ammonia does not guide management and is overutilised in patients with cirrhosis in hospital settings","volume":"53","author":"Hannah","year":"2023","journal-title":"Intern Med J"},{"issue":"3","key":"10.1016\/j.cld.2024.03.008_bib31","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","article-title":"EASL Clinical Practice Guidelines on the management of hepatic encephalopathy","volume":"77","year":"2022","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2024.03.008_bib32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1023\/A:1020645110880","article-title":"Neuropsychological aspects of portal-systemic encephalopathy","volume":"13","author":"Schomerus","year":"1998","journal-title":"Metab Brain Dis"},{"issue":"9","key":"10.1016\/j.cld.2024.03.008_bib33","article-title":"Predicting overt hepatic encephalopathy after TIPS: Value of three minimal hepatic encephalopathy tests","volume":"5","author":"Ehrenbauer","year":"2023","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.cld.2024.03.008_bib34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s11011-022-00913-w","article-title":"Psychometric methods for diagnosing and monitoring minimal hepatic encephalopathy -current validation level and practical use","volume":"37","author":"Hansen","year":"2022","journal-title":"Metab Brain Dis"},{"issue":"5","key":"10.1016\/j.cld.2024.03.008_bib35","doi-asserted-by":"crossref","first-page":"764","DOI":"10.14309\/ajg.0000000000000121","article-title":"Development and validation of a prognostic score to predict covert hepatic encephalopathy in patients with cirrhosis","volume":"114","author":"Labenz","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2024.03.008_bib36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.29146","article-title":"The animal naming test: an easy tool for the assessment of hepatic encephalopathy","volume":"66","author":"Campagna","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2024.03.008_bib37","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jceh.2018.04.010","article-title":"MHE testing in real world scenario","volume":"8","author":"Lauridsen","year":"2018","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2024.03.008_bib38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2015.03.017","article-title":"Hepatic encephalopathy treatment and its effect on driving abilities: a continental divide","volume":"63","author":"Lauridsen","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2024.03.008_bib39","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.3390\/biomedicines11082171","article-title":"The impact of renal function on hepatic encephalopathy following TIPS placement for refractory ascites","volume":"11","author":"Zhao","year":"2023","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.cld.2024.03.008_bib40","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000159","article-title":"Psychological burden of hepatic encephalopathy on patients and caregivers","volume":"11","author":"Fabrellas","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2024.03.008_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40265-018-1019-y","article-title":"Impact of hepatic encephalopathy in cirrhosis on quality-of-life issues","volume":"79","author":"Montagnese","year":"2019","journal-title":"Drugs"},{"issue":"23","key":"10.1016\/j.cld.2024.03.008_bib42","first-page":"7246","article-title":"Minimal hepatic encephalopathy affects daily life of cirrhotic patients: a Viewpoint on clinical consequences and therapeutic opportunities","volume":"11","author":"Faccioli","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"17\u201318","key":"10.1016\/j.cld.2024.03.008_bib43","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1111\/jocn.13298","article-title":"Being an informal caregiver for a relative with liver cirrhosis and overt hepatic encephalopathy: a phenomenological study","volume":"25","author":"Kunzler-Heule","year":"2016","journal-title":"J\u00a0Clin Nurs"},{"issue":"4","key":"10.1016\/j.cld.2024.03.008_bib44","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11011-012-9325-7","article-title":"A\u00a0patients' and caregivers' perspective on hepatic encephalopathy","volume":"27","author":"Montagnese","year":"2012","journal-title":"Metab Brain Dis"},{"issue":"9","key":"10.1016\/j.cld.2024.03.008_bib45","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/ajg.2011.157","article-title":"The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers","volume":"106","author":"Bajaj","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2024.03.008_bib46","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000181","article-title":"Hepatic encephalopathy: a diagnosis for the individual but an experience for the household","volume":"11","author":"Louissaint","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"issue":"10","key":"10.1016\/j.cld.2024.03.008_bib47","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1002\/hep4.2030","article-title":"The emotional burden of caregiving for patients with cirrhosis","volume":"6","author":"Saleh","year":"2022","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.cld.2024.03.008_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jceh.2019.06.002","article-title":"Factors affecting psychological burden on the informal caregiver of patients with cirrhosis: Looking beyond the patient","volume":"10","author":"Shrestha","year":"2020","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2024.03.008_bib49","doi-asserted-by":"crossref","first-page":"284","DOI":"10.14309\/ajg.0000000000002008","article-title":"Systematic review and meta-analysis on the effects of lactulose and rifaximin on patient-reported outcomes in hepatic encephalopathy","volume":"118","author":"Moon","year":"2023","journal-title":"Am J Gastroenterol"},{"issue":"Sup17","key":"10.1016\/j.cld.2024.03.008_bib50","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.12968\/bjon.2020.29.Sup17.S10","article-title":"Early identification of hepatic encephalopathy improves outcomes","volume":"29","author":"Parker","year":"2020","journal-title":"Br J Nurs"},{"issue":"2","key":"10.1016\/j.cld.2024.03.008_bib51","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1097\/SGA.0000000000000434","article-title":"Nursing management of hepatic encephalopathy","volume":"43","author":"Rodenbaugh","year":"2020","journal-title":"Gastroenterol Nurs"},{"issue":"3","key":"10.1016\/j.cld.2024.03.008_bib52","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jceh.2018.05.003","article-title":"Hepatic encephalopathy and astrocyte senescence","volume":"8","author":"Gorg","year":"2018","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2024.03.008_bib53","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1053\/j.gastro.2010.02.015","article-title":"Persistence of cognitive impairment after resolution of overt hepatic encephalopathy","volume":"138","author":"Bajaj","year":"2010","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.cld.2024.03.008_bib54","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/liv.13494","article-title":"The patient buddy app can potentially prevent hepatic encephalopathy-related readmissions","volume":"37","author":"Ganapathy","year":"2017","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.cld.2024.03.008_bib55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jhep.2022.08.034","article-title":"Evaluation of CirrhoCare(R) - a digital health solution for home management of individuals with cirrhosis","volume":"78","author":"Kazankov","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2024.03.008_bib56","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jhep.2013.10.004","article-title":"Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF)","volume":"60","author":"Cordoba","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2024.03.008_bib57","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jhep.2019.12.021","article-title":"Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis","volume":"72","author":"Praktiknjo","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2024.03.008_bib58","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.cgh.2014.12.025","article-title":"A\u00a0model for predicting development of overt hepatic encephalopathy in patients with cirrhosis","volume":"13","author":"Riggio","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.cld.2024.03.008_bib59","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.cgh.2013.12.020","article-title":"Diagnosis of covert hepatic encephalopathy without specialized tests","volume":"12","author":"Nabi","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2024.03.008_bib60","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/hep.29628","article-title":"A\u00a0risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis","volume":"68","author":"Tapper","year":"2018","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2024.03.008_bib61","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.14309\/ajg.0000000000000762","article-title":"Incidence and bedside predictors of the first episode of overt hepatic encephalopathy in patients with cirrhosis","volume":"115","author":"Tapper","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2024.03.008_bib62","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jhep.2023.05.022","article-title":"Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis","volume":"79","author":"Ballester","year":"2023","journal-title":"J\u00a0Hepatol"},{"issue":"10201","key":"10.1016\/j.cld.2024.03.008_bib63","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(19)31894-X","article-title":"Acute liver failure","volume":"394","author":"Stravitz","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cld.2024.03.008_bib64","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cgh.2015.09.028","article-title":"Efficacy of nutritional therapy for patients with cirrhosis and minimal hepatic encephalopathy in a randomized trial","volume":"14","author":"Maharshi","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2024.03.008_bib65","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/hep.21533","article-title":"Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy","volume":"45","author":"Prasad","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2024.03.008_bib66","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep.28598","article-title":"Nonabsorbable disaccharides for hepatic encephalopathy: a systematic review and meta-analysis","volume":"64","author":"Gluud","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2024.03.008_bib67","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/apt.12803","article-title":"Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy","volume":"40","author":"Kimer","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.cld.2024.03.008_bib68","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cgh.2019.08.047","article-title":"Comparative efficacy of treatment options for minimal hepatic encephalopathy: a systematic review and Network meta-analysis","volume":"18","author":"Dhiman","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2024.03.008_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001939.pub2","article-title":"Branched-chain amino acids for people with hepatic encephalopathy","author":"Gluud","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.cld.2024.03.008_bib70","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/hep.29410","article-title":"L-ornithine L-aspartate in bouts of overt hepatic encephalopathy","volume":"67","author":"Sidhu","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2024.03.008_bib71","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/cts.13257","article-title":"Pharmacokinetics\/pharmacodynamics of L-ornithine phenylacetate in overt hepatic encephalopathy and the effect of plasma ammonia concentration reduction on clinical outcomes","volume":"15","author":"Safadi","year":"2022","journal-title":"Clin Transl Sci"},{"issue":"12","key":"10.1016\/j.cld.2024.03.008_bib72","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1016\/j.cgh.2020.10.019","article-title":"Efficacy and safety of ornithine phenylacetate for treating overt hepatic encephalopathy in a randomized trial","volume":"19","author":"Rahimi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2024.03.008_bib73","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/ajg.2013.219","article-title":"A\u00a0randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy","volume":"108","author":"Sharma","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.cld.2024.03.008_bib74","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2024.03.008_bib75","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.1016\/S0168-8278(23)00789-4","article-title":"Rifaximin plus lactulose is more effective than lactulose alone for the prevention of overt hepatic encephalopathy in patients with or without diabetes","volume":"78","author":"Bajaj","year":"2023","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2024.03.008_bib76","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/hep.1840070617","article-title":"Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial","volume":"7","author":"Morgan","year":"1987","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2024.03.008_bib77","article-title":"L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis","volume":"5","author":"Goh","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.cld.2024.03.008_bib78","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/hep.26314","article-title":"Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy","volume":"57","author":"Laleman","year":"2013","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cld.2024.03.008_bib79","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41395-018-0109-5","article-title":"Coil-assisted retrograde transvenous obliteration (CARTO): an alternative treatment option for refractory hepatic encephalopathy","volume":"113","author":"Lee","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2024.03.008_bib80","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jceh.2018.04.008","article-title":"Radiological intervention for shunt related encephalopathy","volume":"8","author":"Nardelli","year":"2018","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2024.03.008_bib81","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/M20-0202","article-title":"The use of rifaximin in the prevention of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt : a randomized controlled trial","volume":"174","author":"Bureau","year":"2021","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.cld.2024.03.008_bib82","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.30690","article-title":"Fecal microbial transplant capsules are safe in hepatic encephalopathy: a phase 1, randomized, placebo-controlled trial","volume":"70","author":"Bajaj","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2024.03.008_bib83","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1053\/j.gastro.2019.01.033","article-title":"Long-term outcomes of fecal microbiota transplantation in patients with cirrhosis","volume":"156","author":"Bajaj","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2024.03.008_bib84","article-title":"Deep hyperammonemic hepatic encephalopathy precipitated by fecal microbiota transplantation for fulminant Clostridioides difficile infection","volume":"10","author":"Eriksen","year":"2022","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"5","key":"10.1016\/j.cld.2024.03.008_bib85","doi-asserted-by":"crossref","first-page":"G400","DOI":"10.1152\/ajpgi.00073.2015","article-title":"GR3027 antagonizes GABAA receptor-potentiating neurosteroids and restores spatial learning and motor coordination in rats with chronic hyperammonemia and hepatic encephalopathy","volume":"309","author":"Johansson","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.cld.2024.03.008_bib86","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2021.03.012","article-title":"A\u00a0pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy","volume":"75","author":"Montagnese","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2024.03.008_bib87","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2015.10.006","article-title":"EASL clinical practice guidelines: liver transplantation","volume":"64","year":"2016","journal-title":"J\u00a0Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108932612400031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108932612400031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T07:34:44Z","timestamp":1719646484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108932612400031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S108932612400031X"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2024.03.008","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebral Aspects of Portal Hypertension","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2024.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}